Stocks
Axsome Therapeutics (AXSM) FCF US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| FCF, bln rub | ? | -78.5 | -108.5 | -117.2 | -145.7 | -132.6 | |||
| Changes by years, y/y, % | +69% | +38% | -100% | +24% | +37.1% | ||||
Axsome Therapeutics. FCF, bln rub
Axsome Therapeutics. FCF, changes, %
Axsome Therapeutics. FCF, sum by quarters, bln rub
Axsome Therapeutics (AXSM) FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| FCF, bln rub | ? | -53.9 | -30.4 | -53.6 | -30.2 | -18.5 | -132.6 | |
| Changes by years, y/y, % | +136% | +9% | +809% | -46% | -66% | |||
| Changes by quarters, q/q, % | -3% | -44% | +76% | -44% | -39% | |||
